Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline IMCR Q1 2026 Earnings Surprise Profitability Defies Expectations with No Reported Revenue Crane Company CR Q1 2026 Earnings EPS Beat Drives Stock Higher FURY Earnings Overview 20260528 Woodward WWD Q1 2026 Earnings EPS Surpasses Estimates by 782 Stock Edges Lower NeOnc Technologies NTHI Edges Lower but Holds Above Key Support as Trading Volume Remains Subdued Guardian Pharmacy Services GRDN Gains Ground as Stock Pushes Toward Key Resistance Launch One Acquisition Corp LPAA Holds Near Resistance With Modest Gains Principal Financial Group PFG Edges Lower Amid Cautious Trading Key Levels in Focus Revolve Group RVLV Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Exponent Inc EXPO Q1 2026 Earnings EPS Beats Estimates Amid Cautious Market Sentiment PRF Technologies PRFX Q2 2024 Earnings Deep EPS Miss as Operating Losses Widen SGU Q1 2026 Earnings Strong Earnings Performance Amid Seasonal Peak Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges KEQU Q1 2026 Earnings Profitability Achieved with EPS of 028 CRK Q1 2026 Earnings Earnings Miss Expectations Amid Challenging Natural Gas Environment AVBC Q1 2026 Earnings EPS Surpasses Estimates Amidst Potential Margin Pressures